• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难治性癌症患者每日输注微小隐孢子虫的毒性和免疫副作用。

Toxic and immunologic side effects of daily C. parvum-infusion in treatment-resistant cancer patients.

作者信息

Mayr A C, Westerhausen M, Senn H J

出版信息

Dev Biol Stand. 1977;38:523-7.

PMID:608546
Abstract

Daily increasing intravenous doses of Corynebacterium parvum (C.p.) up to 5 mg/m2 i.v. X 10-14 days were given to 6 patients with widespread metastatic neoplastic diseases resistant to radio- and chemotherapy. The immunotherapy treatment-cycles were evaluated for toxic and immunologic side effects and also for possible clinical benefit to the patients. Immunotherapy with i.v.-C.p. was moderately well tolerated. Subjective discomfort for the patients (headache, chills, nausea) was not better tolerated with ongoing treatment-doses. After the 3rd day the body temperature rose nearly regularly to 40 degrees and more within 3-4 h after i.v.-C.p. and returned to normal levels about 6-10 h after the infusion was stopped. Hematological values were monitored on day 1, 4, 8, 15. WBC counts rose after an initial moderate decrease to normal levels. Monocyte counts rose also after an initial transient fall to pre-treatment levels. The monocytic activity index of Naphthol-AS-D-Chloro-Acetate-Esterase, correlating with the monocyte turnover, did not show a significant change. Granulocyte counts, especially stabs, increased slightly. Lymphocyte counts, the number and relations of B, T and O-cells, did not change in a uniform typical way. Hemoglobin values fell in all patients, reticulocyte counts increased, and the blood sedimentation rate did not change.

摘要

对6例对放疗和化疗耐药的广泛转移性肿瘤疾病患者,每日静脉注射递增剂量的短小棒状杆菌(C.p.),剂量高达5mg/m²,静脉注射,共10 - 14天。对免疫治疗周期进行了毒性和免疫副作用评估,以及对患者可能的临床获益评估。静脉注射C.p.的免疫治疗耐受性中等良好。随着治疗剂量的持续增加,患者的主观不适(头痛、寒战、恶心)并未得到更好的耐受。在第3天之后,静脉注射C.p.后3 - 4小时内,体温几乎有规律地升至40度及以上,并在输液停止后约6 - 10小时恢复到正常水平。在第1、4、8、15天监测血液学指标。白细胞计数在最初适度下降后升至正常水平。单核细胞计数在最初短暂下降至治疗前水平后也有所上升。与单核细胞周转率相关的萘酚 - AS - D - 氯乙酸酯酶单核细胞活性指数没有显著变化。粒细胞计数,尤其是杆状核粒细胞,略有增加。淋巴细胞计数、B细胞、T细胞和O细胞的数量及比例并没有以统一的典型方式发生变化。所有患者的血红蛋白值下降,网织红细胞计数增加,血沉率没有变化。

相似文献

1
Toxic and immunologic side effects of daily C. parvum-infusion in treatment-resistant cancer patients.难治性癌症患者每日输注微小隐孢子虫的毒性和免疫副作用。
Dev Biol Stand. 1977;38:523-7.
2
NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).4,4'-硫代双(6-叔丁基间甲酚)(CAS编号:96-69-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(饲料研究)
Natl Toxicol Program Tech Rep Ser. 1994 Dec;435:1-288.
3
The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer.静脉输注短小棒状杆菌对乳腺癌女性免疫特征的影响。
Dev Biol Stand. 1977;38:467-70.
4
Clinical trial with Corynebacterium parvum.
Dev Biol Stand. 1977;38:483-5.
5
The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.短小棒状杆菌对乳腺癌患者体液免疫和细胞免疫系统的影响。
Clin Exp Immunol. 1976 Jun;24(3):441-7.
6
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings.皮下注射白细胞介素-3治疗难治性恶性肿瘤患者的I期试验:血液学、免疫学及药效学研究结果
Clin Cancer Res. 1996 Feb;2(2):347-57.
7
The complications of intravenous Corynebacterium parvum infusion.静脉输注短小棒状杆菌的并发症。
Clin Exp Immunol. 1977 Nov;30(2):229-32.
8
Clinical studies with Corynebacterium parvum.微小棒状杆菌的临床研究。
Dev Biol Stand. 1977;38:509-14.
9
Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum.用短小棒状杆菌腹腔内治疗对卵巢癌患者腹腔淋巴细胞细胞毒性的激活作用。
J Biol Response Mod. 1984 Aug;3(4):371-8.
10
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).香豆素(CAS编号91-64-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.

引用本文的文献

1
Immunochemotherapy of breast cancer with Propionibacterium granulosum.用颗粒丙酸杆菌对乳腺癌进行免疫化疗。
Cancer Immunol Immunother. 1983;15(1):23-6. doi: 10.1007/BF00199457.